Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$0.41 - $0.7 $27,125 - $46,312
66,160 Added 14.73%
515,315 $293,000
Q1 2023

May 09, 2023

BUY
$0.41 - $0.87 $55,059 - $116,834
134,292 Added 42.65%
449,155 $197,000
Q4 2022

Feb 14, 2023

BUY
$0.74 - $6.0 $21,892 - $177,510
29,585 Added 10.37%
314,863 $232,000
Q3 2022

Nov 14, 2022

SELL
$0.75 - $6.5 $3,223 - $27,937
-4,298 Reduced 1.48%
285,278 $351,000
Q2 2022

Aug 08, 2022

BUY
$0.8 - $1.57 $66,288 - $130,090
82,860 Added 40.08%
289,576 $237,000
Q1 2022

May 09, 2022

BUY
$1.44 - $3.37 $159,514 - $373,308
110,774 Added 115.46%
206,716 $314,000
Q4 2021

Jan 31, 2022

BUY
$3.17 - $8.23 $304,136 - $789,602
95,942 New
95,942 $304,000

About BRIGHT MINDS BIOSCIENCES INC.


  • Ticker DRUG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,209,900
  • Market Cap $640M
  • Description
  • Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collabor...
More about DRUG
Track This Portfolio

Track Advisor Shares Investments LLC Portfolio

Follow Advisor Shares Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Shares Investments LLC with notifications on news.